venBio Global Strategic Fund II L.P. 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-10-01 10:01 am Purchase | 2020-07-21 | 13D | ALX Oncology Holdings Inc. ALXO | venBio Global Strategic Fund II L.P. | 9,799,331 26.900% | 9,799,331![]() (New Position) | Filing |